Biotechnology Incubator
Biotechnology Incubator
Biotechnology Incubator
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Strategic ContextNational Policy for Science and TechnologyStrategic Priorities for <strong>Biotechnology</strong> and theNational Medical and Health Research Strategic Priorities<strong>Biotechnology</strong> <strong>Incubator</strong>Successful new <strong>Biotechnology</strong> Businesses
Operational ContextGovernmentPrivate Sector‣ National Policy for Science‣ Scientific Research‣ MOH, Universities‣Government Ministries‣<strong>Biotechnology</strong> <strong>Incubator</strong>‣Commercial Development‣Large Scale Business‣ BioScience Park
FACTSThe Economist Intelligence Unit (EIU) forecasts that the five MENAmarkets (led by: Egypt, Jordan, Morocco, Turkey and GCC region)will represent a combined GDP of US$2.3 trillion in 2015.Making the pharmaceutical market in the Middle East & NorthAfrica (MENA) region very attractive.Pharmaceutical Business News
Priority Areas for Saudi Arabia and theregion in Medicine and Healthcare• Diabetes and its complications• Cardiovascular diseases• Cancer• Neurodegenerative diseases• Asthma and Allergies• Communicable Diseases• Genetic Disorders
<strong>Biotechnology</strong><strong>Incubator</strong> Center
What is <strong>Biotechnology</strong>?The use or application of living organisms, cells or molecules to produceproducts, technologies or servicesProducts/services in the biotechnology sector fall into the followingcategories:• Biopharmaceuticals• Agribio & environmental• Diagnostics• Reagents, Chemicals, Materials and Support for R&D incl. Software &Equipment• Bioengineering/Bioprocessing• Suppliers and services
Badir for <strong>Biotechnology</strong> Facilities• Specialized laboratories andoffices for up to 20 biotechcompanies• Central laboratory facilities andservices• Large company facilities andservices for SMEs• Adjacent to major academic &health community• Entrepreneurial culture
Types of <strong>Biotechnology</strong> CompaniesType:Costs toget toMarketYears tomarketRegulatory Potential $$ Risk offailurePharmaceutical >$500M>12 FDA‐ Hi Very Hi!!! Very, veryHi!Agri‐chem $M’s 2‐6 FDA ‐ lo Hi MedMedicalDiagnostics &Devices$M’s 2‐6 FDA‐med Med‐Hi MedBioengineering $M’s 1‐5 ??? Med Med
Scientific Idea, ResearchAdequate<strong>Biotechnology</strong> <strong>Incubator</strong>Innovative andPracticalAvailable Resources
Starting up a Biotech• Need an idea or technology• Novel Intellectual Property (IP)• Novel Target or Therapeutic Approach• Proof of Concept• Validated Target (causes a disease or disorder)• Lead Compounds that mitigate• Model Systems• In vitro• In vivo• animal
Starting up a Biotech• Write a business plan• Get funding for seed money!!!• Grants• <strong>Incubator</strong>s• Angel Investors• Venture Capital• Multiple rounds!!!!
•PATENT EVALUATION•MARKET POTENTIALEVALUATION•DESIGN ACTION PLAN•TECHNICAL DRAWING•PROTOTYPING•MODIFICATION•ANIMAL TRIAL•HUMAN TRIALIF EXISTINGIF NOPOTENTIALIF NOTSUCCESSFULNOT ACCEPTEDNOT ACCEPTEDNOT ACCEPTED
BAE‐S3 is a local based biotechnologybusiness that is working to eradicateDenge Fever and eventually Malaria inSaudi Arabia through the release ofgenetically modified sterile Malemosquitoes that out compete localmosquitoes for the attention of the femalemosquitoes.The same technology can be applied toother areas such as the red date palmweevil
Plant of Eternal SpringIncreasing pressure from the cost ofimported animal feed and the need tomake the most or limited waterresources has encouraged PES todevelop a soil free intensive growingsystem which optimises water usageand crops the whole plant soincreasing the nutritional quality ofthe animal feed.With 300 growing units planned within the next 12‐18months PES should breakeven and move into profit rapidly.
Chitosan Based Wound dressingsIn collaboration with the NationalPrawn company, DSI (DiabetesScience International) are aimingto develop a highly effectivenovel wound dressing basedupon Chitosan from the prawnindustry incorporated withantimicrobial agents anddelivered by the production ofNano‐fibres.
Cluster Theory• A geographically proximate group of incubators andassociated institutions in a particular field linked bycommonalities and complementarities• Where, value of the system as a whole is greater than thesum of its parts• It is observed worldwide that innovation driven centersincluding companies thrive better in clusters
ObservationsClusters can develop organically due to a local strongimpetus but are usually seeded or induced by thegovernment and then evolve organicallyNeeds long term planningTakes decades to mature
Elements of Life Science ClusterR&D Institutionswith strong industryLinkagesLife Science Parks/<strong>Incubator</strong>sIndustrial basecompanies,InnovativeStartupsLife ScienceClusterSupport ServicesCompanies – vendors,suppliers, law firmsSeed Fund, VCGood commonInfrastructure,regulations
Why can <strong>Biotechnology</strong> Incubationsucceed in Saudi Arabia?• A strong scientific and medical research base –and a majorlong‐term commitment to further strengthen scientific andmedical research• Major long‐term commitment to increase non‐oil exports• Establishment of the incubator and the provision of themeans to support new biotechnology ventures• Specific challenges that need biotechnological solutions:– Medicine and Healthcare– Environmental,– Industrial,– Agricultural• Saudi Arabia is a good place to set up and do business
Conclusion• The <strong>Biotechnology</strong> <strong>Incubator</strong> is an important step towardscreating a world‐class cluster of biotechnology businessesthat will bring great benefits to many areas within theKingdom• The <strong>Incubator</strong> builds a link between scientists andentrepreneurs• The success of the <strong>Biotechnology</strong> <strong>Incubator</strong> is the first stepin the creation of a BioScience Park
Jiang Zhameen, Former Chinese Premier
Change language